Casdin Capital’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Hold |
|
|||||
|
2025
Q1 | $399K | Hold |
|
|||||
|
2024
Q4 | $597K | Hold |
|
|||||
|
2024
Q3 | $456K | Sell |
|
|||||
|
2024
Q2 | $976K | Sell |
|
|||||
|
2024
Q1 | $3.6M | Hold |
|
|||||
|
2023
Q4 | $2.89M | Hold |
|
|||||
|
2023
Q3 | $2.45M | Hold |
|
|||||
|
2023
Q2 | $3.5M | Hold |
|
|||||
|
2023
Q1 | $3.98M | Hold |
|
|||||
|
2022
Q4 | $3.89M | Hold |
|
|||||
|
2022
Q3 | $4.17M | Hold |
|
|||||
|
2022
Q2 | $4.94M | Sell |
|
|||||
|
2022
Q1 | $13.5M | Hold |
|
|||||
|
2021
Q4 | $19.6M | Sell |
|
|||||
|
2021
Q3 | $21.4M | Hold |
|
|||||
|
2021
Q2 | $21.8M | Buy |
|